Pharmacology-related:
Aronson, J. K., 2006. ‘Rare diseases and orphan drugs.’ British Journal of Clinical Pharmacology 61(3): 243-5.
Auckland Medical Oncologists, 2010. High Cost and Highly Specialised Medicines. Submission to the Ministerial Panel. [Online] Available: http://202.68.89.83/NR/rdonlyres/A85C256E-C597-4D6D-A2CF-6B6F6E5DF39A/157468/49SCHE_EVI_00DBSCH_INQ_9752_1_A59978_CancerTrialsN.pdf, pp. 4-5.
Boekhout van Solinge, T., 2004. Dealing with Drugs in Europe–An Investigation of European Drug Control Experiences: France, the Netherlands and Sweden. Cullompton, UK: BJu Legal Publishing
Cole, S., 2008. ‘Hope and despair – the funding of Herceptin.’ The Nathaniel Report 25. [Online] Available: http://www.nathaniel.org.nz/?sid=204
Cumming, J., Mays, N., Daubé, J., 2010. ‘How New Zealand has contained expenditure on drugs.’ British Medical Journal 340: c2441, pp. 1224-7.
Daniels, N., 2008. Just Health: Meeting Health Needs Fairly. Cambridge, UK: Cambridge University Press.
Ferrara, N., Hillan, K. J., Novotny, W., 2005. ‘Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy.’ Biochemical and Biophysical Research Communications 333(2): 328-335.
Food and Drug Administration, 2004. Savings From Generic Drugs Purchased at Retail Pharmacies. [Online] Available: http://www.fda.gov/cder/consumerinfo/savingsfromgenericdrugs.htm.
Forman, J., 2010. ‘Submission to the Ministerial Review Panel on access to high-cost medicines.’ Access to Medicines Coalitions. [Online] Available http://www.atmcoalition.org.nz/submissions/submission_260210.
Gillon, R., 2006. ‘PHARMAC and the funding of high-cost pharmaceuticals.’ Paper for Public Consultation, Wellington, NZ: PHARMAC. [Online] Available: http://www.pharmac.govt.nz/2006/12/15/HCM.pdf.
Hadorn, D., 2006. ‘An Ethical Framework for Pharmac’s Subsidy Decisions on High-Cost Pharmaceuticals.’ Paper for Public Consultation, Wellington, NZ: PHARMAC. [Online] Available: http://www.pharmac.govt.nz/2006/12/15/HCM.pdf.
High Cost – Highly Specialised Medicines Development Workshop, 2009. Backgrounder and Discussion Papers. Collaborative Forum into High Cost, Highly Specialised Medicines, Wellington, 17-18 June 2008, Wellington, NZ: NZMA.
Kunkle, E.C., 1967. ‘The ‘Jumpers’ of Maine: A Reappraisal.” Archives of Internal Medicine 119: 355-358.
Mayer, R. J., 2004. ‘Two Steps Forward in the Treatment of Colorectal Cancer.’ New England Journal of Medicine 350(23): 2406.
McCormack, P., Quigley, J., and Hansen, P., 2009. ‘Review of Access to High-Cost, Highly-Specialised Medicines in New Zealand.’ Preliminary Report to New Zealand Ministry of Health, Wellington, NZ. [Online] Available: http://www.nzdoctor.co.nz/media/34741/review-access-hchs-medicines-in-nz09%5B1%5D.pdf.
McCormack, P., Quigley, J., and Hansen, P., 2010. ‘Review of Access to High-Cost, Highly-Specialised Medicines in New Zealand.’ Report to New Zealand Ministry of Health, Wellington, NZ. [Online] Available: http://www.beehive.govt.nz/sites/all/files/Review%20of%20Access%20to%20High%20Cost%20Highly%20Specialised%20Medicines%2031%20April%202010.pdf.
Ministry of Health, 2011. Cancer: Historical Summary 1948-2008. New Zealand Ministry of Health, Wellington, NZ. [Online] Available: http://www.moh.govt.nz/moh.nsf/indexmh/dataandstatistics-subjects-cancer-historicalsummary-1948-2008.
National Organisation for Rare Disorders, 2011. Join NORD in Advocacy. [Online] Available: http://www.rarediseases.org/advocacy
PHARMAC, 2006. ‘PHARMAC and the funding of high-cost pharmaceuticals.’ Paper for Public Consultation, Wellington, NZ: PHARMAC. [Online] Available: http://www.pharmac.govt.nz/2006/12/15/HCM.pdf.
PHARMAC, 2006. Operating policies and procedures of the pharmaceutical management agency. Pharmaceutical Management Agency, Wellington, NZ: PHARMAC. [Online] Available: http://www.pharmac.govt.nz/2005/12/22/231205.pdf
PHARMAC, 2011. Online Pharmaceutical Schedule. Pharmaceutical Management Agency, Wellington, NZ: PHARMAC. [Online] Available: http://www.pharmac.govt.nz/2011/11/01/Schedule.pdf
PHARMAC, 2011. Statement of Intent 2011/12 – 2013/14, Pharmaceutical Management Agency, Wellington, NZ. [Online] Available: http://www.pharmac.govt.nz/2011/07/07/2011-12%20SOI.pdf.
Rose, G., 2002. ‘Sick Individuals and Sick Populations.’ In L. Gostin, ed. Public Health Law and Ethics: A Reader, Berkeley, CA: University of California Press, pp. 58-66.
Rowland, D., Telyuko, A. V., 1991. ‘Soviet Health Care from two perspectives.’ Health Affairs 10(3): 71-86.
Saint-Hilaire, M., Saint-Hilaire, J., Granger, L., 1986. ‘Jumping Frenchmen of Maine.’ Neurology 36(9): 1269–1.
Scottish Medicines Consortium, 2006. Re-Submission on bevacizumab100mg/4ml and 400mg/16ml solution for intravenous infusion (Avastin ®). National Health Service Scotland. [Online] Available: http://www.scottishmedicines.org.uk/files/bevacizumab__Avastin__Resubmissionn_May_06_FINAL_for_website.pdf
Education-related:
Anderson, V., 1992. ‘A Teacher Development Project in Transactional Strategy Instruction for Teachers of Severely Reading-Disabled Adolescents.’ Teacher Training and Education 8(4): 391-403.
Apling, R. N., Jones, N. L., 2005. Individuals with Disabilities Education Act (IDEA): Analysis of Changes Made by P.L. 108-446. Congressional Research Service: The Library of Congress. [Online] Available: http://www.policyarchive.org/handle/10207/bitstreams/198.pdf
Barbaresi, W. J., Katusic, S. K., Colligan, R. C., Weaver, A. L., Jacobsen, S. J., 2005. ‘Math Learning Disorder: Incidence in a Population-Based Birth Cohort, 1976–82.’Ambulatory Pediatrics 5: 281-289.
Beitchman, J. H., Young, A. R., 1997. ‘Learning Disorders with a Special Emphasis on Reading Disorders: A Review of the Past 10 Years.’ Journal of the American Academy of Child and Adolescent Psychiatry 36(8): 1020-1032.
Cabrera, A. F., Colbeck, C. L., Terenzini, P. T., 2001. ‘Developing performance indicators for assessing classroom teaching practices and student learning.’Research in Higher Education 42(3): 327-352.
Eachus, H. T., 2001. ‘Generating Responses in Vegetative Children.’ Proceedings from the 2001 Technology and Persons With Disabilities Conference 2001, California State University. [Online] Available: http://www.csun.edu/cod/conf/2001/proceedings/0277eachus.htm
Hanushek, E. A., Rivkin, S. G., 2007. ‘Pay, Working Conditions, and Teacher Quality.’ The Future of Children 17(1): 69-86.
Parks v. Pavkovic. 1985. 753 F.2d 1397.
Roberts, M., 2008. ‘The Individuals With Disabilities Education Act: Why Considering Individuals One at a Time Creates Untenable Situations for Students and Educators.’UCLA Law Review 1041: 1041-1094.
Texas Division of Special Education, 1999. ‘Individuals with Disabilities Education Act. Final Regulations.’ Texas Education Agency. [Online] Available: http://ritter.tea.state.tx.us/special.ed/rules/pdf/idea99sxs.pdf
Timothy W. v. Rochester School District. 1989. 875 F.2d 954.
U.S. Department of Education, 2004. Building the Legacy: IDEA 2004. [Online] Available: http://idea.ed.gov/
U.S. Department of Education, 2006. Fiscal Year 2007 Budget Request Advances NCLB Implementation and Pinpoints Competitiveness. Press releases archive. [Online] Available: http://www2.ed.gov/news/pressreleases/2006/02/02062006.html
U.S. Department of Education, National Center for Education Statistics, 2011. Digest of Education Statistics, 2010. U.S. Department of Education. [Online] Available: http://nces.ed.gov/fastfacts/display.asp?id=64
United Nations, [no date]. Disability and the UN. [Online] Available: http://www.un.org/disabilities/default.asp?id=240
Washburn-Moses, L., Rosenberg, M. S., 2008. ‘Alternative Route Special Education Teacher Preparation Programs Guidelines.’ Teacher Education and Special Education: The Journal of the Teacher Education Division of the Council for Exceptional Children 31: 257-267
Other works used:
Feinberg, J., 1989. The Moral Limits of the Criminal Law Volume 3: Harm to Self. Oxford Scholarship Online.
Gift, T. L., Marrazzo, J., 2007. ‘Cost-Effectiveness Analysis.’ In Behavioral Interventions for Prevention and Control of Sexually Transmitted Diseases, eds. S. O. Aral, J. M. Douglas Jr, New York: Springer Science+Business Media, LLC, pp. 482-499.
Mintrom, M., 2012. Contemporary policy analysis. New York, NY: Oxford University Press.
Weimer, D. L., Vining, A. R., 2005. Policy analysis: concepts and practice. Upper Saddle River, NJ: Pearson Prentice Hall.